Empo Health Secures Publications, APMA Seal, and SOC 2 Compliance
Empo Health has achieved a peer-reviewed publication, the APMA Seal of Approval, and SOC 2 Type 2 compliance, demonstrating its technology's patient adherence and clinical utility.
Empo Health announced in late July the attainment of several significant milestones. The company, which develops FDA-listed technology for at-home foot monitoring, has received a peer-reviewed publication, the American Podiatric Medical Association (APMA) Seal of Approval, and SOC 2 Type 2 compliance.
These achievements highlight the patient adherence and clinical utility of Empo Health's technology for early provider intervention. The APMA's endorsement validates the safety and efficacy of the company's devices within the podiatric field.
Furthermore, the company's new SOC 2 Type 2 compliance demonstrates a strong commitment to data security and customer information confidentiality. This standard is particularly critical in the health technology sector, which handles sensitive patient data.
Empo Health's technology is designed to enable remote foot monitoring, allowing healthcare professionals to intervene promptly in potential issues. The company aims to improve patient outcomes and reduce healthcare costs through proactive monitoring.